AMDA Pocket Guidelines

Dementia Depression Delirium

AMDA GUIDELINES App Bundle brought to you courtesy of AMDA and Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1512442

Contents of this Issue

Navigation

Page 41 of 53

Appendices 42 Appendix A: Antipsychotic Agents Antipsychotic a Generic Name (Brand Name) Indications and Dosage Quetiapine (Seroquel ® ) Major Depressive Disorder (in combination with antidepressants): • Oral: Extended Release (ER) – 50 mg daily; may increase by 50 mg once daily to an effective dose. (max: 300 mg daily) Agitation associated with dementia (off-label): • Oral: Immediate Release (IR) – 25 to 75 mg daily in 1 to 2 divided doses; increase gradually based on response and tolerability (max: 400–800 mg per day). If no response in 4 weeks, begin taper to discontinuation. Agitation associated with delirium (off-label): • Oral: Immediate Release (IR) – 50 mg twice daily; may increase as necessary (max: 400 mg per day) Psychosis in Parkinson Disease (off-label): • Oral: Immediate Release (IR) – 25 mg daily in 1 to 2 divided doses; increase gradually based on response and tolerability (max: 200 mg per day). Risperidone (Risperdal ® ) Major Depressive Disorder (in combination with antidepressants): • Oral: 0.25 to 0.5 mg daily; increase based on response and tolerability (max: 3 mg per day) Agitation associated with delirium (off-label): • Oral: 0.25 mg twice daily; increase based on response and tolerability (max: 4 mg per day with a lower max if >65 years of age) Psychosis in Parkinson Disease (off-label): • Oral: 0.5 mg daily in 1 or 2 divided doses; increasing based on response and tolerability (max: 2 mg per day). Doses >1 mg daily are associated with higher risk of extrapyramidal systems. If no response in 4 weeks, begin taper to discontinuation. Ziprasidone (Geodon ® ) Major Depressive Disorder (in combination with antidepressants) (off-label): • Oral: 20 mg twice daily; may increase dose by 20 mg twice daily at weekly increments based on response and tolerability (max: 80 mg twice daily) Psychosis in Parkinson Disease (off-label): • Oral: 20 to 40 mg daily in 1 to 2 divided dose; increase daily dose by 20 to 40 mg increments every 2 to 7 days (max: 160 mg per day). If no response in 4 weeks, begin taper to discontinuation. a Other antipsychotic agents such as Lurasidone (Latuda) and Brexpiprazole (Rexulti) may be recommended by a psychiatrist for certain clinical conditions.

Articles in this issue

view archives of AMDA Pocket Guidelines - Dementia Depression Delirium